Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.51 USD | +5.62% | +2.27% | +150.56% |
Mar. 22 | H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating | MT |
Mar. 21 | Health Care Up on Drug Sales Optimism -- Health Care Roundup | DJ |
Financials (USD)
Sales 2024 * | 3.6M | Sales 2025 * | 400K | Capitalization | 251M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -79M | EV / Sales 2024 * | 69.8 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 629 x |
P/E ratio 2024 * |
-5.59
x | P/E ratio 2025 * |
-3.34
x | Employees | 50 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.77% |
1 day | +5.62% | ||
1 week | +2.27% | ||
Current month | +1.35% | ||
1 month | -15.70% | ||
3 months | +0.67% | ||
6 months | +200.67% | ||
Current year | +150.56% |
Managers | Title | Age | Since |
---|---|---|---|
Lara Sullivan
CEO | Chief Executive Officer | 51 | 19-12-10 |
Pamela Connealy
DFI | Director of Finance/CFO | 63 | 21-06-30 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Flavin
FOU | Founder | 55 | 18-06-10 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 21-08-31 |
Darren Cline
BRD | Director/Board Member | 59 | 21-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 4.27 | -2.51% | 437,825 |
24-05-07 | 4.38 | +1.62% | 703,939 |
24-05-06 | 4.31 | -1.60% | 352,022 |
24-05-03 | 4.38 | -0.68% | 818,440 |
24-05-02 | 4.41 | +0.23% | 189,064 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+150.56% | 251M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- PYXS Stock